Filing Details
- Accession Number:
- 0001354488-17-000231
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-02-08 16:01:13
- Reporting Period:
- 2017-02-07
- Filing Date:
- 2017-02-08
- Accepted Time:
- 2017-02-08 16:01:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1410098 | Cormedix Inc. | CRMD | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1368953 | Antony Pfaffle | C/O Cormedix Inc. 1430 Us Highway 206, Suite 200 Bedminster NJ 07921 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-02-07 | 10,000 | $0.68 | 10,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-02-07 | 10,000 | $2.00 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 Par Value Per Share | Stock Option (right to buy) | Acquisiton | 2017-02-07 | 10,000 | $0.00 | 10,000 | $0.68 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 70,000 | 2022-12-05 | No | 4 | M | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 Par Value Per Share | stock Option (right to buy) | $3.13 | 2020-03-30 | 20,000 | 20,000 | Direct | |
| Common Stock, $0.001 Par Value Per Share | Stock Option (right to buy) | $2.10 | 2021-01-14 | 30,000 | 30,000 | Direct | |
| Common Stock, $0.001 Par Value Per Share | Stock Option (right to buy) | $0.90 | 2023-03-22 | 210,000 | 210,000 | Direct | |
| Default | Stock Option (right to buy) | $2.02 | 2024-01-09 | 30,000 | 30,000 | Direct | |
| Common Stock, $0.001 Par Value Per Share | Stock Option (right to buy) | $2.02 | 2024-01-09 | 100,000 | 100,000 | Direct | |
| Common Stock, $0.001 Par Value Per Share | Stock Option (right to buy) | $2.27 | 2024-04-01 | 100,000 | 100,000 | Direct | |
| Common Stock, $0.001 Par Value Per Share | Stock Option (right to buy) | $5.00 | 2025-02-24 | 75,000 | 75,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2020-03-30 | 20,000 | 20,000 | Direct |
| 2021-01-14 | 30,000 | 30,000 | Direct |
| 2023-03-22 | 210,000 | 210,000 | Direct |
| 2024-01-09 | 30,000 | 30,000 | Direct |
| 2024-01-09 | 100,000 | 100,000 | Direct |
| 2024-04-01 | 100,000 | 100,000 | Direct |
| 2025-02-24 | 75,000 | 75,000 | Direct |
Footnotes
- This exercise and sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person on September 19, 2016.
- These options vested as follows: fifty percent (50%) on the date of issuance of the CE mark certification, which occurred on July 5, 2013, and (b) fifty percent (50%) on December 31, 2013.
- These options vested as follows: 1/3 on March 30, 2010; an additional 1/3 on March 30, 2011; and the remaining 1/3 on March 30, 2012.
- These options vested on January 14, 2012.
- These options vest based on performance milestones running through December 31, 2014.
- The options vest in full on the first anniversary of the date of grant.
- The options vested 100% on January 10, 2014.
- The options vested 100% on April 2, 2014.
- These options were granted on February 24, 2015, and vested immediately.
Billionaire Hedge Funds
